血管紧张素转换酶抑制剂(ACEI)能明显改善伴左室收缩功能不全心力衰竭患者的存活率,然而临床使用现状并不乐观,尤其是在65岁以上老年人,尽管近年来其使用情况日有改善。迄今,尚缺乏老年人与非老年人心力衰竭使用ACEI现状对照分析,本文就此进行了比较。受试对象来自美国33所医疗 Angiotensin converting enzyme inhibitors (ACEI) can significantly improve the survival rate of patients with heart failure with left ventricular systolic dysfunction, but the current status of clinical use is not optimistic, especially in the elderly over the age of 65, although in recent years its use day has improved. To date, there is still a lack of comparative analysis of the current status of ACEI in the elderly and non-elderly with heart failure. Subjects from the United States 33 medical